INR 189.4
(-0.16%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 291.47 Million INR | -22.33% |
2022 | 375.29 Million INR | 21.53% |
2021 | 308.81 Million INR | 15.93% |
2020 | 266.37 Million INR | 42.8% |
2019 | 186.54 Million INR | -18.37% |
2018 | 228.51 Million INR | 8.37% |
2017 | 210.86 Million INR | 32.68% |
2016 | 158.92 Million INR | 114.09% |
2015 | 74.23 Million INR | -35.71% |
2014 | 115.47 Million INR | 23.18% |
2013 | 93.74 Million INR | 6.71% |
2012 | 87.84 Million INR | 20.22% |
2011 | 73.06 Million INR | -11.06% |
2010 | 82.15 Million INR | 32.38% |
2009 | 62.05 Million INR | 27.01% |
2008 | 48.86 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 291.47 Million INR | -22.33% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 309.21 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 291.47 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 375.29 Million INR | 21.53% |
2022 Q2 | 311.28 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 375.29 Million INR | 0.0% |
2021 Q4 | 308.81 Million INR | 0.0% |
2021 FY | 308.81 Million INR | 15.93% |
2021 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 273 Million INR | 0.0% |
2020 Q4 | 266.37 Million INR | 0.0% |
2020 FY | 266.37 Million INR | 42.8% |
2020 Q2 | 209.6 Million INR | 0.0% |
2019 Q4 | 186.54 Million INR | 0.0% |
2019 Q2 | 200.27 Million INR | 0.0% |
2019 FY | 186.54 Million INR | -18.37% |
2018 Q4 | 228.51 Million INR | 0.0% |
2018 Q2 | 238.14 Million INR | 0.0% |
2018 FY | 228.51 Million INR | 8.37% |
2017 FY | 210.86 Million INR | 32.68% |
2017 Q2 | 202.87 Million INR | 0.0% |
2017 Q4 | 210.86 Million INR | 0.0% |
2016 FY | 158.92 Million INR | 114.09% |
2016 Q4 | 170.09 Million INR | 0.0% |
2016 Q2 | 108.15 Million INR | 0.0% |
2015 FY | 74.23 Million INR | -35.71% |
2015 Q2 | 80.84 Million INR | 0.0% |
2015 Q4 | 74.23 Million INR | 0.0% |
2014 Q4 | 115.47 Million INR | 0.0% |
2014 FY | 115.47 Million INR | 23.18% |
2014 Q2 | 106.57 Million INR | 0.0% |
2013 Q4 | 93.74 Million INR | 0.0% |
2013 Q2 | 88.87 Million INR | 0.0% |
2013 FY | 93.74 Million INR | 6.71% |
2012 Q2 | 81.16 Million INR | 0.0% |
2012 Q4 | 87.84 Million INR | 0.0% |
2012 FY | 87.84 Million INR | 20.22% |
2011 FY | 73.06 Million INR | -11.06% |
2011 Q4 | 73.06 Million INR | 0.0% |
2010 FY | 82.15 Million INR | 32.38% |
2009 FY | 62.05 Million INR | 27.01% |
2008 FY | 48.86 Million INR | 0.0% |
2008 Q4 | 48.86 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Add-Shop E-Retail Limited | 159.2 Million INR | -83.083% |
Concord Drugs Limited | 249.88 Million INR | -16.644% |
Gujarat Terce Laboratories Limited | 161.67 Million INR | -80.286% |
Gujarat Themis Biosyn Limited | 197.37 Million INR | -47.678% |
Hindustan Bio Sciences Limited | 25.7 Million INR | -1034.101% |
Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -44.587% |
KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 70.746% |
Kwality Pharmaceuticals Limited | 1.71 Billion INR | 83.017% |
Makers Laboratories Limited | 569.18 Million INR | 48.79% |
Medi-Caps Limited | 63.01 Million INR | -362.543% |
Parmax Pharma Limited | 117.56 Million INR | -147.922% |
PRAVEG LIMITED | 767.53 Million INR | 62.024% |
Sastasundar Ventures Limited | 1.5 Billion INR | 80.576% |
Smruthi Organics Limited | 485.72 Million INR | 39.991% |
SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 82.996% |
Sunil Healthcare Limited | 902.83 Million INR | 67.715% |
Syschem (India) Limited | 1.07 Billion INR | 72.777% |
Transchem Limited | 6.72 Million INR | -4237.44% |
Trinity League India Limited | 876 Thousand INR | -33173.516% |
Tyche Industries Limited | 101.64 Million INR | -186.77% |
Zenlabs Ethica Limited | 301.35 Million INR | 3.278% |
Beryl Drugs Limited | 85.63 Million INR | -240.366% |
ANG Lifesciences India Limited | 1.66 Billion INR | 82.458% |
Bacil Pharma Limited | 1.12 Million INR | -25717.183% |
BDH Industries Limited | 312.53 Million INR | 6.738% |
Cian Healthcare Limited | 1.03 Billion INR | 71.82% |
Chemo Pharma Laboratories Limited | 2.12 Million INR | -13597.18% |
Colinz Laboratories Limited | 24.1 Million INR | -1109.193% |
Mercury Laboratories Limited | 171.18 Million INR | -70.266% |
Deccan Health Care Limited | 111.33 Million INR | -161.799% |
DECIPHER LABS LIMITED | 117.72 Million INR | -147.591% |
Phaarmasia Limited | 211.49 Million INR | -37.817% |
MedPlus Health Services Limited | 14.27 Billion INR | 97.958% |
Parnax Lab Limited | 1.17 Billion INR | 75.103% |
Patidar Buildcon Limited | 25.57 Million INR | -1039.825% |
Sanjivani Paranteral Limited. | 155.06 Million INR | -87.97% |
SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -97383.612% |
Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -594.453% |
Trident Lifeline Limited | 331.26 Million INR | 12.01% |
Denis Chem Lab Limited | 289.82 Million INR | -0.571% |
Vista Pharmaceuticals Limited | 175.16 Million INR | -66.399% |
Panchsheel Organics Limited | 340.2 Million INR | 14.323% |
Zenith Healthcare Limited | 24.03 Million INR | -1112.715% |
Vivanza Biosciences Limited | 148.63 Million INR | -96.107% |
Ishita Drugs and Industries Limited | 8.87 Million INR | -3185.347% |
SHELTER PHARMA LIMITED | 20.99 Million INR | -1288.642% |
Vasundhara Rasayans Limited | 53.64 Million INR | -443.322% |
Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 70.978% |
Roopa Industries Limited | 493.08 Million INR | 40.888% |
PANJON LTD. | 25.38 Million INR | -1048.312% |
Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -39.836% |
TIAAN CONSUMER LIMITED | 14.97 Million INR | -1845.898% |
Anuh Pharma Limited | 1.54 Billion INR | 81.13% |
Crestchem Limited | 23.94 Million INR | -1117.171% |
Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -2074.383% |
Sandu Pharmaceuticals Limited | 118.22 Million INR | -146.548% |
Fredun Pharmaceuticals Limited | 1.86 Billion INR | 84.34% |
Trimurthi Limited | 101.36 Thousand INR | -287465.114% |
Shukra Pharmaceuticals Limited | 201.97 Million INR | -44.314% |
Norris Medicines Limited | 278.17 Million INR | -4.782% |
Veerhealth Care Limited | 62.78 Million INR | -364.282% |
Lactose (India) Limited | 536.39 Million INR | 45.66% |
OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 65.015% |
Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 74.226% |
Gennex Laboratories Limited | 535.21 Million INR | 45.54% |
Godavari Drugs Limited | 957.86 Million INR | 69.57% |
Zenotech Laboratories Limited | 156.64 Million INR | -86.071% |
Shree Ganesh Remedies Limited | 488.36 Million INR | 40.316% |
Bharat Parenterals Limited | 2.65 Billion INR | 89.028% |
Coral Laboratories Limited | 281.83 Million INR | -3.419% |
Evoq Remedies Limited | 116.23 Million INR | -150.771% |
Kerala Ayurveda Limited | 1.05 Billion INR | 72.441% |
KOBO BIOTECH LIMITED | 2.04 Billion INR | 85.733% |
Natural Capsules Limited | 1.47 Billion INR | 80.268% |
Auro Laboratories Limited | 433.09 Million INR | 32.7% |